神经退行作为生态系统失败:预防和治疗的新范式
Gordana Velikic1,2, Gordana Supic3,4, Dusica L Maric5
1Hajim School of Engineering, University of Rochester, Rochester, NY 14627, USA.
International journal of molecular sciences
|November 27, 2025
概括
神经退行性疾病可能源于系统生态系统的崩,而不仅仅是大脑. 了解器官-大脑轴和外体信号提供了新的治疗途径,在发生显著的神经元损伤之前.
科学领域:
- 神经科学是一个神经科学.
- 系统生物学 系统生物学
- 免疫学 免疫学 免疫学
背景情况:
- 传统的神经退行性疾病模型侧重于大脑病理,忽视了外围贡献.
- 几十年来失败的疾病修饰试验凸显了以大脑为中心的方法的局限性.
- 新出现的证据表明神经退行性疾病的早期外周症状.
研究的目的:
- 提出理解神经退行症的范式转变,将其重新定义为系统性生态系统崩.
- 引入神经退行性疾病的精密生态系统医学概念.
- 探索器官-大脑轴,外体信号传导和蛋白质菌株在疾病进展中的作用.
主要方法:
- 使用α-synucleinopathies作为模型的前景审查.
- 系统相互作用的分析,包括微生物失衡,免疫功能障碍和环境压力因素.
- 神经退行症的概念化作为器官间平衡的崩.
主要成果:
- 神经退行被概念化为系统生态系统崩的后期表现.
- 错误折叠的蛋白质,如α-synuclein,作为类似的介质,具有不同的菌株,可能通过外体传播.
- 在不同的器官环境中,不同的α-synuclein形状菌株会出现.
结论:
- 了解系统相互作用揭示了在显著的神经退行之前潜在的治疗窗口.
- 精准生态系统医学提供了预防和治疗的多目标战略.
- 重构神经退行开辟了再生疗法和患者护理的新途径.
相关概念视频
Alzheimer's Disease: Treatment
772
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
772
Neurogenesis and Regeneration of Nervous Tissue
1.5K
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
1.5K
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Neural Regulation
43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K
Disorders of the Nervous Tissue
2.5K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
2.5K


